<?xml version="1.1" encoding="utf-8"?>
<rdf:RDF xmlns:OMEXlib="http://omex-library.org/"
   xmlns:bqbiol="http://biomodels.net/biology-qualifiers/"
   xmlns:bqmodel="http://biomodels.net/model-qualifiers/"
   xmlns:dc="http://purl.org/dc/terms/"
   xmlns:foaf="http://xmlns.com/foaf/0.1/"
   xmlns:local="http://omex-library.org/NewOmex.omex/NewModel.rdf#"
   xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
  <rdf:Description rdf:about="http://omex-library.org/BIOMD0000000683.omex">
    <bqmodel:isDescribedBy rdf:resource="local:00001"/>
    <ns1:keyword xmlns:ns1="http://prismstandard.org/namespaces/basic/2.0/">Biomodels</ns1:keyword>
    <ns2:description xmlns:ns2="http://purl.org/dc/elements/1.1/">&lt;body xmlns="http://www.w3.org/1999/xhtml"&gt;
  &lt;p&gt;This a model from the article:      &lt;br/&gt;
  &lt;strong&gt;Specific therapy regimes could lead to long-term immunological control of HIV.&lt;/strong&gt;
  &lt;br/&gt;
          Wodarz D, Nowak MA.      &lt;em&gt;Proc Natl Acad Sci U S A&lt;/em&gt;
          1999 Dec 7;96(25):14464-9      &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/10588728"&gt;10588728&lt;/a&gt;
          ,      &lt;br/&gt;
  &lt;strong&gt;Abstract:&lt;/strong&gt;
  &lt;br/&gt;
          We use mathematical models to study the relationship between HIV and the immune
system during the natural course of infection and in the context of different
antiviral treatment regimes. The models suggest that an efficient cytotoxic T
lymphocyte (CTL) memory response is required to control the virus. We define CTL
memory as long-term persistence of CTL precursors in the absence of antigen.
Infection and depletion of CD4(+) T helper cells interfere with CTL memory
generation, resulting in persistent viral replication and disease progression.
We find that antiviral drug therapy during primary infection can enable the
development of CTL memory. In chronically infected patients, specific treatment
schedules, either including deliberate drug holidays or antigenic boosts of the
immune system, can lead to a re-establishment of CTL memory. Whether such
treatment regimes would lead to long-term immunologic control deserves
investigation under carefully controlled conditions.      &lt;/p&gt;
  &lt;p&gt;This model was taken from the      &lt;a href="http://www.cellml.org/models"&gt;CellML repository&lt;/a&gt;
          and automatically converted to SBML.      &lt;br/&gt;
          The original model was:      &lt;a href="http://models.cellml.org/exposure/2ce81f8abff72fcd37f9b8ed21133b99"&gt;
    &lt;strong&gt;Wodarz D, Nowak MA. (1999) - version=1.0&lt;/strong&gt;
  &lt;/a&gt;
  &lt;br/&gt;
          The original CellML model was created by:      &lt;br/&gt;
  &lt;strong&gt;Catherine Lloyd&lt;/strong&gt;
  &lt;br/&gt;
          c.lloyd@auckland.ac.nz      &lt;br/&gt;
          The University of Auckland      &lt;br/&gt;&lt;/p&gt;
  &lt;p&gt;This model originates from BioModels Database: A Database of Annotated Published Models (http://www.ebi.ac.uk/biomodels/). It is copyright (c) 2005-2011 The BioModels.net Team.      &lt;br/&gt;
          To the extent possible under law, all copyright and related or neighbouring rights to this encoded model have been dedicated to the public domain worldwide. Please refer to      &lt;a href="http://creativecommons.org/publicdomain/zero/1.0/" title="Creative Commons CC0"&gt;CC0 Public Domain Dedication&lt;/a&gt;
          for more information.      &lt;/p&gt;
  &lt;p&gt;In summary, you are entitled to use this encoded model in absolutely any manner you deem suitable, verbatim, or with modification, alone or embedded it in a larger context, redistribute it, commercially or not, in a restricted way or not..      &lt;br/&gt;
  &lt;br/&gt;
          To cite BioModels Database, please use:      &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/20587024" target="_blank"&gt;Li C, Donizelli M, Rodriguez N, Dharuri H, Endler L, Chelliah V, Li L, He E, Henry A, Stefan MI, Snoep JL, Hucka M, Le Nov√®re N, Laibe C (2010) BioModels Database: An enhanced, curated and annotated resource for published quantitative kinetic models. BMC Syst Biol., 4:92.&lt;/a&gt;&lt;/p&gt;
&lt;/body&gt;</ns2:description>
    <ns3:title xmlns:ns3="http://purl.org/dc/elements/1.1/">Specific therapy regimes could lead to long-term immunological control of HIV</ns3:title>
    <ns4:thumbnail xmlns:ns4="http://www.collex.org/schema#"
       rdf:resource="http://omex-library.org/BIOMD0000000683.omex/BIOMD0000000683.png"/>
  </rdf:Description>
  <rdf:Description rdf:about="local:00001">
    <ns5:identifier xmlns:ns5="http://purl.org/dc/elements/1.1/"
       rdf:resource="http://identifiers.org/doi/10.1073/pnas.96.25.14464"/>
    <ns6:label xmlns:ns6="http://www.w3.org/2000/01/rdf-schema#">Dominik Wodarz &amp; Martin A. Nowak. Specific therapy regimes could lead to long-term immunological control of HIV. Proceedings of the National Academy of Sciences 96, 25 (1999).</ns6:label>
  </rdf:Description>
</rdf:RDF>

